CIVISTA MEDICAL CENTER
1. Target Overview & Investment Thesis
CIVISTA MEDICAL CENTER is a 98-bed suburban community hospital in CHARLES, MD with $154.9M in net patient revenue and a 2.9% operating margin. The hospital serves a payer mix of 51.1% Medicare, 3.2% Medicaid, and 45.6% commercial.
Thesis: Turnaround. Our ML models identify $11.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 2.9% to 10.3% (+736bps).
| Net Revenue HCRIS | $154.9M |
| Current EBITDA COMPUTED | $4.5M |
| Operating Margin COMPUTED | 2.9% |
| Occupancy HCRIS | 75.7% |
| Revenue / Bed COMPUTED | $1.6M |
| Net-to-Gross HCRIS | 84.7% |
| Distress Probability ML | 48.5% |
2. Market Context & Competitive Position
MD has 59 Medicare-certified hospitals with a median operating margin of -8.3%. The target's margin of 2.9% places it above the state median. Among 27 size-comparable peers (49-196 beds), the median margin is -7.2%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (49-196), prioritizing same-state peers. 27 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| CIVISTA MEDICAL CENTER (Target) | MD | 98 | $154.9M | 2.9% |
| MERCY MEDICAL CENTER | MD | 173 | $561.3M | -3.3% |
| ST. AGNES HOSPITAL | MD | 183 | $506.7M | -12.2% |
| MEDSTAR UNION MEMORIAL HOSPITA | MD | 191 | $409.3M | -8.7% |
| AHC WHITE OAK MEDICAL CENTER | MD | 196 | $323.2M | -43.2% |
| NORTHWEST HOSPITAL CENTER | MD | 193 | $289.0M | -8.3% |
| MEMORIAL EASTON | MD | 143 | $287.6M | -4.1% |
| MEDSTAR SOUTHERN MARYLAND HOSP | MD | 188 | $270.0M | -13.8% |
| CARROLL COUNTY GENERAL HOSPITA | MD | 165 | $226.9M | -3.3% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $11.4M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $3.3M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $3.1M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $3.1M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $1.9M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $99K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $4.5M |
| + RCM Uplift | +$11.4M |
| Pro Forma EBITDA | $15.9M |
| Current Margin | 2.9% |
| Pro Forma Margin | 10.3% |
| WC Released (1x) | $5.9M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $7.0M | $143.9M | 20.65x | 83.2% |
| Base (11x exit) | 10.0x | 11.0x | $7.0M | $160.5M | 23.04x | 87.3% |
| Bull Case | 9.0x | 11.0x | $6.3M | $200.4M | 31.97x | 100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $6.3M | $220.5M | 35.17x | 103.8% |
| Bear Case | 11.0x | 10.0x | $7.7M | $84.6M | 11.04x | 61.7% |
| Bear (11x exit) | 11.0x | 11.0x | $7.7M | $95.5M | 12.47x | 65.6% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Standard execution risk | RCM improvement requires management buy-in and 12-18 month implementation timeline |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 27 hospitals with 49-196 beds
- Same-state prioritization (n=28)
- Comp margins: P25=-13.6% / P50=-7.2% / P75=-1.8%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.